# To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers

> **NCT07514780** · PHASE1 · RECRUITING · sponsor: **JW Pharmaceutical** · enrollment: 104 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JW0061 SAD
- **DRUG:** JW0061 MAD
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07514780
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-13
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-04-30
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07514780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07514780, "To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07514780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*